Keyphrases
Repurchase
100%
Initial Public Offerings
75%
Overvaluation
61%
Firm Performance
57%
Venture Capital
55%
Innovation Activity
47%
Institutional Ownership
44%
Open Market Repurchase
41%
Firm Innovation
38%
Shareholding
35%
Investor Sentiment
35%
New Drugs
35%
Asset Pricing
35%
Investment Analysis
35%
Older Dogs
35%
Simultaneous Equations
35%
Accelerated Share Repurchases
35%
Analyst Recommendations
35%
Innovation Performance
35%
Financial Disclosure
35%
Biopharmaceuticals
35%
Information Disclosure
35%
Investor Information
35%
Biotechnology
35%
Information Content
35%
Corporate Finance
35%
Tangible Information
35%
Intangible Information
35%
Firm Profitability
35%
Operating Performance
35%
Stock Performance
35%
Motivation
35%
Venture Capitalists
35%
Employee Welfare
35%
Bubble Periods
35%
Pharmaceutical Industry
35%
Public Research
35%
Spillover Effect
35%
Institutional Investors
35%
Cross-sectional Stock Returns
35%
Finance Research
35%
Public Development
35%
Trade Secrets Laws
35%
Underpricing
35%
Board of Directors
35%
Corporate Social Responsibility
35%
Buyback
29%
Listed Companies
29%
Share Repurchases
26%
Endogeneity Problem
23%
Economics, Econometrics and Finance
Share Repurchase
100%
Firm Performance
79%
Investors
75%
Initial Public Offering
75%
Research and Development
70%
Ownership
61%
Venture Capital
55%
Finance
47%
Spillover Effect
44%
Capital Market Returns
44%
Profit
35%
Information Value
35%
Investor Sentiment
35%
Asset Pricing
35%
Corporate Innovation
35%
Institutional Investor
35%
Life Cycle
35%
Corporate Finance
35%
Market Share
35%
Venture Capitalist
35%
Multiple Equation Model
35%
Corporate Social Responsibility
35%
Cash Flow
29%
Corporate Governance
24%
Expenditure
17%
Intangible Asset
17%
Arbitrage
17%
Financial Statement
17%
Factor Model
17%
New Orders
17%
Financing Investment
17%
Industry
16%
Accounting Policy
15%
Firm Value
11%
Litigation Costs
8%
Investment
8%
Ownership Structure
8%
Capital Structure
8%
Pricing
5%
Accounting
5%
Social Sciences
Firm Performance
88%
USA
52%
Finance
47%
Research and Development
47%
Corporate Social Responsibility
35%
Ownership
35%
Shareholdings
35%
Venture Capital
35%
Asset Pricing
35%
Investors
35%
Corporate Finance
35%
Corporate Innovation
35%
Scientific Methods
35%
Financing Investment
35%
Corporate Governance
32%
Authors
23%
Investment
17%
Capital Structure
17%
Ownership Structure
17%
Financial Statement
11%
Research Results
11%
Management Operations
11%